|
Temps Différé
Nasdaq
15:30:02 09/10/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 0,0551 USD | -19,62% |
|
0,00% | -25,88% |
| 29/08/25 | Altamira Therapeutics Ltd. publie ses résultats semestriels au 30 juin 2025 | CI |
| 29/08/25 | Transcript : Altamira Therapeutics Ltd., H1 2025 Earnings Call, Aug 29, 2025 |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0,43% | +2,76% | +4,46% | -3,50% | +9,27% | +37,29% | +105,39% | +402,56% | +1 313,85% | 1 043 Md | |
| +1,45% | +1,64% | -2,57% | +0,43% | +25,74% | +36,18% | +64,14% | +62,38% | +117,21% | 618 Md | |
| +1,41% | +5,23% | +10,22% | +10,67% | +21,04% | +19,89% | +85,48% | +150,65% | +336,84% | 481 Md | |
| +2,56% | +1,21% | -1,01% | +16,77% | +38,75% | +66,91% | +39,76% | +82,72% | +128,55% | 351 Md | |
| +1,45% | +3,50% | +2,90% | +6,65% | +9,02% | +21,87% | +42,64% | -1,32% | +48,46% | 338 Md | |
| +1,17% | +2,37% | +6,66% | -4,18% | +8,67% | +11,71% | +35,14% | +55,28% | +55,99% | 269 Md | |
| +0,89% | +1,08% | +2,99% | -10,15% | -12,99% | -7,28% | +10,52% | +33,27% | +135,44% | 244 Md | |
| +2,22% | +3,32% | +6,43% | +14,52% | +27,22% | +40,95% | +53,35% | +101,46% | +147,41% | 220 Md | |
| +2,58% | +4,20% | +3,55% | +11,85% | +22,88% | +29,19% | +100,93% | +121,53% | +99,79% | 182 Md | |
| +2,14% | +2,61% | -11,65% | -20,27% | -21,52% | -32,76% | -60,12% | -19,61% | +88,59% | 166 Md | |
| +1,24% | +1,38% | +1,46% | +16,23% | +13,19% | +11,67% | -15,11% | -32,99% | -16,14% | 159 Md | |
| +1,46% | +1,18% | -2,00% | +2,86% | +12,65% | +23,10% | +43,78% | +184,39% | +493,98% | 128 Md | |
| -0,60% | -2,85% | -7,76% | +2,54% | +10,14% | +32,97% | +4,95% | +3,47% | +19,27% | 122 Md | |
| +1,34% | +4,29% | +5,53% | +18,69% | +14,72% | +24,15% | +108,29% | +366,35% | +469,16% | 108 Md | |
| +0,83% | +1,00% | -3,66% | -6,49% | -13,54% | -15,68% | -30,28% | -15,56% | +2,71% | 95,16 Md | |
| +0,84% | -1,66% | -2,97% | -10,69% | -4,08% | +6,71% | +16,03% | +0,52% | -18,72% | 91,9 Md | |
| +12,09% | +16,45% | +63,16% | +189,00% | +650,29% | +703,71% | +117,26% | -27,48% | - | 78,65 Md | |
| +0,81% | +1,32% | -7,77% | +11,52% | -3,50% | +30,70% | -10,45% | +36,36% | +89,12% | 73,85 Md | |
| +1,58% | +0,69% | +3,88% | -1,25% | +12,44% | +16,67% | -11,09% | -24,96% | +41,46% | 66,07 Md | |
| Moyenne | +1,98% | +0,04% | +3,78% | +12,90% | +43,18% | +55,68% | +36,87% | +77,84% | +197,39% | 254,43 Md | |
| Moyenne pondérée par Capi. | +1,55% | +0,38% | +3,09% | +5,71% | +23,73% | +37,50% | +56,50% | +140,56% | +399,71% |
- Bourse
- Actions
- Action CYTOF
- Action CYTO
- Secteur Altamira Therapeutics Ltd.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
